PHASQ / PhaseBio Pharmaceuticals, Inc. - Insider Trading and Ownership Report - SEC Form 3, 4, 5

페이즈바이오제약(PhaseBio Pharmaceuticals, Inc.)
US ˙ OTCPK ˙ US7172241090
이 기호는 더 이상 활성화되지 않습니다.

내부자 지분12,488,536 shares
내부자 센티멘트 점수

내부자 센티멘트 점수를 통해서 내부자들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

이는 내부자의 누적도가 가장 높은 기업을 식별하는 정교하고 복합적인 지수를 분석하는 계량 모델의 결과 값입니다. 스코어링 모델은 이전 90일 동안 매수한 "내부자의 순 숫자", "매수한 주식의 총합", "내부자가 소유한 주식의 총합"의 조합을 사용합니다. 점수는 0에서 100 사이이며, 점수가 높을수록 피어(Peer: 동종업계 경쟁기업)에 대한 누적도가 높다는 것을 나타내며, 평균은 50입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

내부 경영진 센티멘트 점수

내부 경영진 센티멘트 점수를 통해서 내부 경영진들이 법인 지분을 매입하는 기업들에 대해서 알아볼 수 있습니다.

내부 거래의 정의에 따라 내부 경영진(기업 임원)도 내부자이지만, 다른 내부자(10% 주주 및 이사회 구성원)들과는 달리 내부 경영진은 매일 회사에서 근무하며, 거래 시에 자신의 자금을 사용합니다. (많은 경우에 10% 주주 및 이사회 구성원은 다른 사람의 자금을 관리하는 자금 관리자입니다.) 따라서 내부 경영진(기업 임원: Officer)의 내부 거래는 훨씬 더 중요하며 올바른 분석이 필요합니다.

내부자 센티멘트 점수와 마찬가지로 임원 감정 점수는 가장 높은 수준의 임원 축적을 가진 기업을 식별하는 정교하고 복합적인 지수 퀀트(Multi-factor quantitative) 모델의 결과입니다.

업데이트 주기: 일별

내부자의 누적도가 가장 높은 기업 목록을 확인할 수 있는 내부자들의 최다 선택(Insiders Top Picks)을 참고하십시오.

주요 내부자 지표

이 수치는 해당 기업이 다양한 내부자 지표에 따라 어떻게 순위를 매겨지는 지를 설명합니다. 백분위 순위는 이 기업이 미국 시장의 다른 기업들과 어떻게 비교되는지 보여줍니다. 순위가 높을수록 더 나은 상황에 있다는 것을 의미합니다.

예를 들어, 일반적으로 내부자의 매입은 긍정적인 지표라고 간주되어지기 때문에, 내부자의 매입(내부자의 매각, 역시도)가 적은 기업보다 내부자의 매입이 많은 기업은 순위가 높을 것입니다.

내부자의 순 매입(순위)

N/A

내부자의 순 매입(Net Number of Insiders Buying)는 내부자 매수의 총 수에서 지난 90일 동안의 내부자 매도의 총 수를 뺀 값입니다. 여기에 백분위 순위가 표시됩니다(범위: 0~100%).

내부자가 매입한 플로트 비율 (순위)

N/A

"내부자가 매입한 플로트 비율(Percent of Float Bought by Insiders)"은 내부자가 매입한 주식의 총 수에서 내부자가 매도한 주식의 총 수를 뺀 값을 전체 플로트로 나눈 값에 100을 곱한 값입니다. * ((내부자가 매입한 주식의 총 수 - 내부자가 매도한 주식의 총 수) ÷ 전체 플로트) x 100

내부자 트레이딩 차트

PhaseBio Pharmaceuticals, Inc. 내부자의 매매 거래는 아래 차트에 나와 있습니다. 내부자들은 기업의 임원(내부 경영진), 이사 또는 주요 투자자입니다. 일반적으로 내부자가 중요한 비공개 정보를 기반으로 자신이 속한 기업을 거래하는 것은 불법으로 간주됩니다. 이것은 내부자가 자신의 기업 내에서 행하는 모든 거래가 불법이라는 것을 뜻은 아닙니다. 그러나 그들은 자신들의 모든 거래를 양식 4를 통해 SEC에 보고해야만 합니다.

내부자의 명단 및 이익 지표

아래 표는 공개된 내부자의 목록이며, SEC에 공개된 제출 문서에서 자동으로 생성됩니다. "이름", "가장 최근의 직급", "이사, 임원 또는 10% 주주"에 대한 지정 외에도 최근에 공개된 보유 주식에 대한 정보를 보여줍니다. 또한 가능한 경우 내부자의 과거 거래 실적도 확인 가능합니다. 과거 거래 실적은 내부자가 실제 "공개 시장"(Open market) 매입 거래를 수행한 실적을 가중 평균한 값입니다. 이 계산 방법에 대한 자세한 내용은 유튜브 웨비나 를 참조하시면 됩니다.

See our leaderboard of most profitable insider traders.

내부자 평균 이익률 (%) 소유
지분
주식
분할

Report errors via our new Insider Auditing Tool

내부자의 매입 내역 추적: 단기 이익 분석

이 섹션에서는 PHASQ / PhaseBio Pharmaceuticals, Inc.에서 계획되지 않은 "공개 시장"(Open market)의 내부자가 매입한 모든 상품의 수익성을 분석합니다. 이 분석을 통해서 내부자가 비정상적인 수익을 지속적으로 창출하는지 파악하는 데 도움이 되며, 이러한 분석은 수행해볼 가치가 있습니다. 이 분석은 개별 거래 후 1년 동안 수행한 것이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 "공개 시장"(Open market)에서의 매입을 보여줍니다.

거래일 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최고까지
일수
최고에서
가격
최고
이익 ($)
최고 수익률 (%)
2021-08-18 Thorp Clay 10,000 3.0000 10,000 3.0000 30,000 76 4.05 10,500 35.00
2021-08-18 Hutson Nancy J 3,000 3.0800 3,000 3.0800 9,240
2020-12-03 HARRIGAN EDMUND 6,000 4.1200 6,000 4.1200 24,720
2020-11-24 Thorp Clay 2,000 3.5000 2,000 3.5000 7,000
2020-11-23 Thorp Clay 3,000 3.6700 3,000 3.6700 11,010
2018-12-17 Hutson Nancy J 1,000 4.4600 1,000 4.4600 4,460
2018-12-13 Ballance David James 1,000 3.9400 1,000 3.9400 3,940
2018-12-13 Mow Jonathan P 1,000 3.6900 1,000 3.6900 3,690
2018-12-11 York Michael 1,500 3.8800 1,500 3.8800 5,820

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades
내부자 매매의 실적: 단기 손실 분석

이 섹선에서는 PHASQ / PhaseBio Pharmaceuticals, Inc.에서 이루어진 "공개 시장(Open market)"에서의 모든 계획되지 않은 내부자 매매의 단기 손실 회피(Short-term loss avoidance)를 분석합니다. 일관된 손실 회피 패턴을 통해서 향후 매매 거래가 가격 하락을 초래할 수도 있음을 예상할 수 있습니다. 이 분석은 각 각 매매 거래 후 1년 동안의 자료이며, 결과는 이론 값입니다. .

아래 표는 사전 거래 계획(Automated trading plan)에 포함되지 않은 가장 최근의 공개 시장에서의 매매를 보여줍니다.

거래일 내부자 보고된
지분
보고된
가격
조정된
지분
조정된
가격
가격 기준 최저까지
일수
최저에서
가격
회피된
최대 손실($)
회피된
최대 손실율(%)
2022-10-25 NEW ENTERPRISE ASSOCIATES 13 LP 1,784,109 0.1470 1,784,109 0.1470 262,264 8 0.0701 -137,198 -52.31
2021-05-20 Burkhardt Glen 3,811 3.2900 3,811 3.2900 12,538
2020-11-23 Burkhardt Glen 3,497 3.4500 3,497 3.4500 12,065

조정된 가격은 분할 조정 가격입니다. 조정된 지분은 분할 조정 지분입니다.

PHASQ / PhaseBio Pharmaceuticals, Inc. Insider Trades
거래 내역

전체 거래 내역을 보려면 링크 아이콘을 클릭하세요. 10b5-1 자동 거래 계획의 일부로 보고된 거래는 10b-5 열에 X 표시가 나타납니다.

보고일 거래일 양식 내부자 티커 증권 소유권 코드 10b5-1 직접 행사
가격
단위
가격
단위
변동
가치
변동 (단위: 1,000)
잔여
옵션
잔여
주식
2023-05-19 2023-05-19 4 Humphries William D. PHAS Common Stock M - Exercise D 2,538 2,538
2023-05-19 2023-05-19 4 Thorp Clay PHAS Common Stock M - Exercise D 3,750 36,693
2023-05-19 2023-05-19 4 van den Broek Richard PHAS Common Stock A - Award D 3,750 0
2023-05-19 2023-05-19 4 Loewy Caroline M PHAS Common Stock M - Exercise D 3,750 3,750
2023-05-19 2023-05-19 4 Sapir Alex PHAS Common Stock M - Exercise D 3,750 3,750
2023-05-19 2023-05-19 4 HARRIGAN EDMUND PHAS Common Stock M - Exercise D 3,750 9,750
2023-05-19 2023-05-19 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3,750 37,510
2022-10-26 2022-10-25 4 NEW ENTERPRISE ASSOCIATES 13 LP PHAS Common Stock S - Sale D 0.1470 -1,784,109 -262 4,857,525
2022-05-24 2022-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 0.6813 10,917 7 41,236
2022-05-24 2022-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 0.6813 10,918 7 132,502
2022-05-24 2022-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 0.6813 4,831 3 8,463
2022-05-24 2022-05-20 4 Birchall Jonathan PHAS Common Stock A - Award D 0.6813 20,000 14 20,000
2022-05-24 2022-05-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 0.7900 -11,248 -9 0
2022-05-24 2022-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 0.6813 11,248 8 11,248
2022-05-24 2022-05-20 4 Sharp John P PHAS Common Stock A - Award D 0.6813 6,026 4 65,767
2022-05-20 2021-08-18 4/A Hutson Nancy J Held in an individual retirement account for the benefit of the Reporting Person PHAS Common Stock P - Purchase I 3.0800 3,000 9 4,000
2022-05-20 2022-05-19 4 Thorp Clay PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 Humphries William D. PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 Sapir Alex PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Restricted Stock Units A - Award D 3,750 3,750
2022-05-20 2022-05-19 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.84 17,500 17,500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 1.13 87,500 87,500
2022-02-28 2022-02-24 4 Burkhardt Glen PHAS Restricted Stock Unit A - Award D 18,750 18,750
2022-02-28 2022-02-24 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 1.13 115,500 115,500
2022-02-28 2022-02-24 4 Sharp John P PHAS Restricted Stock Unit A - Award D 24,750 24,750
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 1.13 52,500 52,500
2022-02-28 2022-02-24 4 Birchall Jonathan PHAS Restricted Stock Unit A - Award D 11,250 11,250
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 1.13 87,500 87,500
2022-02-28 2022-02-24 4 Arnold Susan Elizabeth PHAS Restricted Stock Unit A - Award D 18,750 18,750
2022-02-28 2022-02-24 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 1.13 115,500 115,500
2022-02-28 2022-02-24 4 Lee John Sang PHAS Restricted Stock Unit A - Award D 24,750 24,750
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 1.13 385,000 385,000
2022-02-28 2022-02-24 4 Mow Jonathan P PHAS Restricted Stock Unit A - Award D 82,500 82,500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 1.13 87,500 87,500
2022-02-28 2022-02-24 4 Hanson Kristopher PHAS Restricted Stock Unit A - Award D 18,750 18,750
2021-11-23 2021-11-19 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2.0100 2,559 5 30,319
2021-11-23 2021-11-19 4 Mow Jonathan P PHAS Common Stock A - Award D 2.0100 5,623 11 172,473
2021-11-23 2021-11-19 4 Sharp John P PHAS Common Stock A - Award D 2.0100 2,017 4 59,741
2021-11-23 2021-11-19 4 Hanson Kristopher PHAS Common Stock A - Award D 2.0100 1,545 3 3,632
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock S - Sale D 2.3700 -5,766 -14 0
2021-11-23 2021-11-19 4 Burkhardt Glen PHAS Common Stock A - Award D 2.0100 5,766 12 5,766
2021-11-09 2021-11-08 4 Birchall Jonathan PHAS Employee Stock Option (right to buy) A - Award D 3.37 3.3700 250,000 842 250,000
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3.15 3.1500 -7,400 -23 0
2021-11-08 2021-11-08 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3.1500 7,400 23 33,760
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 3.15 3.1500 -1,500 -5 7,400
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) M - Exercise D 2.26 2.2600 -24,860 -56 2,256
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 3.1500 1,500 5 26,360
2021-11-08 2021-11-05 4 Hutson Nancy J PHAS Common Stock M - Exercise D 2.2600 24,860 56 24,860
2021-11-03 2021-11-03 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.68 1.6800 -7,500 -13 90,582
2021-11-03 2021-11-03 4 Sharp John P PHAS Common Stock M - Exercise D 1.6800 7,500 13 57,724
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1.24 1.2400 -20,000 -25 108,767
2021-11-03 2021-11-03 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 20,000 25 166,850
2021-09-15 2021-09-14 4 Humphries William D. PHAS Non-employee Director Stock Option (right to buy) A - Award D 2.80 28,000 28,000
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1.74 -4,519 0
2021-09-03 2021-07-12 4/A Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1.7400 4,519 8 27,760
2021-09-03 2021-08-03 4/A Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.68 -7,500 98,082
2021-09-03 2021-08-03 4/A Sharp John P PHAS Common Stock M - Exercise D 1.6800 7,500 13 50,224
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1.24 -20,000 128,767
2021-08-30 2021-08-27 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 20,000 25 146,850
2021-08-19 2021-08-18 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 3.0800 3,000 9 4,000
2021-08-18 2021-08-18 4 Thorp Clay PHAS Common Stock P - Purchase D 3.0000 10,000 30 32,943
2021-08-04 2021-08-03 4 Sharp John P PHAS Common Stock A - Award D 1.6800 7,500 13 50,224
2021-07-14 2021-07-12 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 1.7400 4,519 8 27,760
2021-06-04 2021-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-06-04 2021-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.53 14,000 14,000
2021-05-24 2021-05-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 2.8000 5,257 15 23,241
2021-05-24 2021-05-20 4 York Michael PHAS Common Stock A - Award D 2.8000 2,897 8 7,059
2021-05-24 2021-05-20 4 Hanson Kristopher PHAS Common Stock A - Award D 2.8000 1,088 3 2,087
2021-05-24 2021-05-20 4 Mow Jonathan P PHAS Common Stock A - Award D 2.8000 3,964 11 126,850
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock S - Sale D 3.2900 -3,811 -13 0
2021-05-24 2021-05-20 4 Burkhardt Glen PHAS Common Stock A - Award D 2.8000 3,811 11 3,811
2021-05-24 2021-05-20 4 Sharp John P PHAS Common Stock A - Award D 2.8000 1,419 4 42,724
2021-02-09 2021-02-05 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 4.31 234,000 234,000
2021-02-09 2021-02-05 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4.31 36,000 36,000
2021-02-09 2021-02-05 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 4.31 36,000 36,000
2021-02-09 2021-02-05 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 4.31 36,000 36,000
2021-02-09 2021-02-05 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 4.31 76,500 76,500
2021-02-09 2021-02-05 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 4.31 76,500 76,500
2021-02-09 2021-02-05 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 4.31 36,000 36,000
2020-12-04 2020-12-03 4 HARRIGAN EDMUND PHAS Common Stock P - Purchase D 4.1200 6,000 25 6,000
2020-11-24 2020-11-24 4 Thorp Clay PHAS Common Stock P - Purchase D 3.5000 2,000 7 22,943
2020-11-24 2020-11-23 4 Thorp Clay PHAS Common Stock P - Purchase D 3.6700 3,000 11 20,943
2020-11-23 2020-11-20 4 Sharp John P PHAS Common Stock A - Award D 3.0000 1,305 4 41,305
2020-11-23 2020-11-20 4 Hanson Kristopher PHAS Common Stock A - Award D 3.0000 999 3 999
2020-11-23 2020-11-20 4 York Michael PHAS Common Stock A - Award D 3.0000 2,662 8 4,162
2020-11-23 2020-11-20 4 Ballance David James PHAS Common Stock A - Award D 3.0000 919 3 8,519
2020-11-23 2020-11-20 4 Mow Jonathan P PHAS Common Stock A - Award D 3.0000 3,643 11 122,886
2020-11-23 2020-11-20 4 Arnold Susan Elizabeth PHAS Common Stock A - Award D 3.0000 4,832 14 17,984
2020-11-23 2020-11-23 4 Burkhardt Glen PHAS Common Stock S - Sale D 3.4500 -3,497 -12 0
2020-11-23 2020-11-20 4 Burkhardt Glen PHAS Common Stock A - Award D 3.0000 3,497 10 3,497
2020-11-18 2020-11-16 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock J - Other I 10,586 15,432
2020-11-18 2020-11-16 4 Thorp Clay PHAS Common Stock J - Other D 2,144 17,943
2020-11-18 2020-11-16 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock J - Other I -52,397 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1.15 1.1500 -5,423 -6 0
2020-10-05 2020-10-01 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1.1500 5,423 6 13,152
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) M - Exercise D 1.15 1.1500 -5,423 -6 0
2020-10-05 2020-02-27 4 Arnold Susan Elizabeth PHAS Common Stock M - Exercise D 1.1500 5,423 6 7,729
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1.24 -10,000 148,767
2020-08-24 2020-08-21 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 10,000 12 119,243
2020-08-17 2020-08-14 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.69 -5,000 105,582
2020-08-17 2020-08-14 4 Sharp John P PHAS Common Stock M - Exercise D 1.6900 5,000 8 40,000
2020-06-05 2020-06-03 4 Sapir Alex PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 4,909 4,909
2020-06-05 2020-06-03 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 0.00 16,000 16,000
2020-06-05 2020-06-03 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-06-05 2020-06-03 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-06-05 2020-06-03 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-06-05 2020-06-03 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-06-05 2020-06-03 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 4.86 16,000 16,000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5.19 20,000 20,000
2020-02-14 2020-02-12 4 Burkhardt Glen PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 5.19 100,000 100,000
2020-02-14 2020-02-12 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 Sapir Alex PHAS Employee Stock Option (right to buy) A - Award D 5.19 32,000 32,000
2020-02-14 2020-02-12 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 5.19 100,000 100,000
2020-02-14 2020-02-12 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 5.19 55,000 55,000
2020-02-14 2020-02-12 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5.19 290,000 290,000
2019-10-07 2019-10-07 4 Hanson Kristopher PHAS Employee Stock Option (right to buy) A - Award D 4.17 66,000 66,000
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) M - Exercise D 1.24 -19,000 158,767
2019-09-10 2019-09-06 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 19,000 24 109,243
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.44 -5,000 4,038
2019-08-22 2019-08-21 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.69 -10,000 110,582
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1.4400 5,000 7 35,000
2019-08-22 2019-08-21 4 Sharp John P PHAS Common Stock M - Exercise D 1.6900 10,000 17 30,000
2019-07-03 2019-07-01 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14.0000 -459 -6 415,959
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14.0000 -255 -4 52,397
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14.0000 -180 -3 162,890
2019-07-03 2019-07-01 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14.0000 -2,014 -28 1,818,638
2019-06-20 2019-06-18 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock S - Sale I 14.0000 -63 -1 416,418
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock S - Sale I 14.0000 -35 -0 52,655
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock S - Sale I 14.0000 -25 -0 163,074
2019-06-20 2019-06-18 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock S - Sale I 14.0000 -277 -4 1,820,656
2019-05-24 2019-05-22 4 Sharp John P PHAS Employee Stock Option (right to buy) M - Exercise D 1.69 -15,000 120,582
2019-05-24 2019-05-22 4 Sharp John P PHAS Common Stock M - Exercise D 1.6900 15,000 25 20,000
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 1.24 -19,131 0
2019-05-21 2019-05-20 4 Mow Jonathan P PHAS Common Stock M - Exercise D 1.2400 19,131 24 90,243
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Employee stock option (right to buy) M - Exercise D 2.27 -19,913 0
2019-05-21 2019-05-17 4 Mow Jonathan P PHAS Common Stock M - Exercise D 2.2700 19,913 45 71,112
2019-05-13 2019-05-09 4 Thorp Clay PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 11,000 11,000
2019-05-13 2019-05-09 4 Hutson Nancy J PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 11,000 11,000
2019-05-13 2019-05-09 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 9,167 9,167
2019-05-13 2019-05-09 4 HARRIGAN EDMUND PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 4,583 4,583
2019-05-13 2019-05-09 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 2,750 2,750
2019-05-13 2019-05-09 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 11,000 11,000
2019-05-13 2019-05-09 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 13.23 11,000 11,000
2019-03-01 2019-02-27 4 TUFTS LINDA PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 36,000 36,000
2019-03-01 2019-02-27 4 Ballance David James PHAS Employee Stock Option (right to buy) A - Award D 3.15 45,000 45,000
2019-03-01 2019-02-27 4 Hutson Nancy J PHAS Employee Stock Option (right to buy) A - Award D 3.15 8,900 8,900
2019-03-01 2019-02-27 4 Klein Peter Justin PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 36,000 36,000
2019-03-01 2019-02-27 4 Lee John Sang PHAS Employee Stock Option (right to buy) A - Award D 3.15 100,000 100,000
2019-03-01 2019-02-27 4 Loewy Caroline M PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 8,900 8,900
2019-03-01 2019-02-27 4 Sharp John P PHAS Employee Stock Option (right to buy) A - Award D 3.15 100,000 100,000
2019-03-01 2019-02-27 4 Thorp Clay PHAS Employee Stock Option (right to buy) A - Award D 3.15 36,000 36,000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 23,000 23,000
2019-03-01 2019-02-27 4 van den Broek Richard PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 22,000 22,000
2019-03-01 2019-02-27 4 York Michael PHAS Employee Stock Option (right to buy) A - Award D 3.15 45,000 45,000
2019-03-01 2019-02-27 4 Mukhopadhyay Bibhash PHAS Non-employee Director Stock Option (right to buy) A - Award D 3.15 36,000 36,000
2019-03-01 2019-02-27 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 3.15 263,000 263,000
2019-03-01 2019-02-27 4 Arnold Susan Elizabeth PHAS Employee Stock Option (right to buy) A - Award D 3.15 45,000 45,000
2018-12-17 3/A Ballance David James PHAS Common Stock D 6,600
2018-12-17 2018-12-17 4 Hutson Nancy J Held in an individual retirement account for the benefit of the reporting person PHAS Common Stock P - Purchase I 4.4600 1,000 4 1,000
2018-12-17 2018-12-13 4 Ballance David James PHAS Common Stock P - Purchase D 3.9400 1,000 4 7,600
2018-12-17 2018-12-13 4 HARRIGAN EDMUND PHAS Employee Stock Option (right to buy) A - Award D 3.65 68,966 68,966
2018-12-17 2018-12-13 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.6900 1,000 4 51,199
2018-12-13 2018-12-10 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.8500 800 3 50,199
2018-12-13 2018-12-07 4/A Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.8900 700 3 49,399
2018-12-11 2018-12-10 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.8500 800 3 51,699
2018-12-11 2018-12-07 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock P - Purchase I 3.8800 2,200 9 50,899
2018-12-11 2018-12-07 4 Sharp John P PHAS Common Stock P - Purchase D 3.8400 5,000 19 5,000
2018-12-11 2018-12-11 4 York Michael PHAS Common Stock P - Purchase D 3.8800 1,500 6 1,500
2018-12-06 2018-12-04 4 Thorp Clay PHAS Common Stock P - Purchase D 3.1300 4,000 13 15,799
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series D Preferred Stock C - Conversion I -1,124,301 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock C - Conversion I -437,706 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -4,349 -22 437,706
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series C-1 Preferred Stock X - Other I 0.1200 181,190 22 442,055
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -181,190 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock C - Conversion I -3,279,627 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock S - Sale I 5.0000 -1,177 -6 3,279,627
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Series B Preferred Stock X - Other I 0.1200 49,030 6 3,280,804
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0.12 -49,030 0
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock P - Purchase I 5.0000 1,800,000 9,000 6,641,634
2018-10-24 2018-10-22 4 NEW ENTERPRISE ASSOCIATES 13 LP See Note 2 PHAS Common Stock C - Conversion I 4,841,634 4,841,634
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock C - Conversion D -2,303 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock S - Sale D 5.0000 -3 -0 2,303
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Series B Preferred Stock X - Other D 0.1200 103 0 2,306
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Warrants to Purchase Series B Preferred Stock X - Other D 0.12 -103 0
2018-10-24 2018-10-22 4 Klein Peter Justin PHAS Common Stock C - Conversion D 2,303 2,303
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock C - Conversion D -2,306 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Series B Preferred Stock M - Exercise D 0.1200 103 0 2,306
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0.12 -103 0
2018-10-24 2018-10-22 4 Arnold Susan Elizabeth PHAS Common Stock C - Conversion D 2,306 2,306
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series D Preferred Stock C - Conversion I -740,337 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock C - Conversion I -1,664,217 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -2,734 -14 1,664,217
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Series C-1 Preferred Stock X - Other I 0.1200 113,891 14 1,666,951
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -113,891 0
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock P - Purchase I 5.0000 600,000 3,000 3,004,554
2018-10-24 2018-10-22 4 ASTRAZENECA PLC By Zeneca, Inc. PHAS Common Stock C - Conversion I 2,404,554 2,404,554
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I -226,061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I -24,709 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I -272,107 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I -40,420 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I -13,558 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I -149,320 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I -94,874 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I -1,044,764 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I -13,609 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I -174,699 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I -4,846 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I -3,862 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I -42,530 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I -52,690 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -994 -5 40,420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock X - Other I 0.1200 41,414 5 41,414
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -41,414 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -104 -1 13,558
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock X - Other I 0.1200 4,309 1 13,662
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -4,309 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -1,139 -6 149,320
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock X - Other I 0.1200 47,458 6 150,459
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock X - Other I 0.12 -47,458 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -42 -0 94,874
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock X - Other I 0.1200 1,731 0 94,916
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0.12 -1,731 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -458 -2 1,044,764
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock X - Other I 0.1200 19,061 2 1,045,222
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock X - Other I 0.12 -19,061 0
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5.0000 150,000 750 416,481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266,481 266,481
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4,846 4,846
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5.0000 12,487 62 163,099
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150,612 150,612
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5.0000 137,513 688 1,820,933
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1,683,420 1,683,420
2018-10-24 2018-10-22 4 Hatteras Venture Advisors III, LLC By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52,690 52,690
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Series B Preferred Stock C - Conversion I -3,505 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock C - Conversion D -310 0
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Series B Preferred Stock M - Exercise D 0.1200 310 0 310
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Warrants to Purchase Series B Preferred Stock M - Exercise D 0.12 -310 0
2018-10-24 2018-10-22 4 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock C - Conversion I 3,505 48,699
2018-10-24 2018-10-22 4 Mow Jonathan P PHAS Common Stock C - Conversion D 310 310
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series D Preferred Stock C - Conversion I -226,061 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series D Preferred Stock C - Conversion I -24,709 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series D Preferred Stock C - Conversion I -272,107 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock C - Conversion I -40,420 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock C - Conversion I -13,558 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock C - Conversion I -149,320 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock C - Conversion I -94,874 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock C - Conversion I -1,044,764 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series AA Preferred Stock C - Conversion I -13,609 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series AA Preferred Stock C - Conversion I -174,699 0
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Series 1 Preferred Stock C - Conversion I -4,846 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series 1 Preferred Stock C - Conversion I -3,862 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series 1 Preferred Stock C - Conversion I -42,530 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Series 1 Preferred Stock C - Conversion I -52,690 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -994 -5 40,420
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 41,414 5 41,414
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -41,414 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -104 -1 13,558
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 4,309 1 13,662
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -4,309 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -1,139 -6 149,320
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 47,458 6 150,459
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -47,458 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -42 -0 94,874
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 1,731 0 94,916
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -1,731 0
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -458 -2 1,044,764
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 19,061 2 1,045,222
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -19,061 0
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock P - Purchase I 5.0000 150,000 750 416,481
2018-10-24 2018-10-22 4 Thorp Clay By Venture Capital Multiplier Fund PHAS Common Stock C - Conversion I 266,481 266,481
2018-10-24 2018-10-22 4 Thorp Clay By Catalysta Ventures, LLC PHAS Common Stock C - Conversion I 4,846 4,846
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock P - Purchase I 5.0000 12,487 62 163,099
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Affiliates III, LP PHAS Common Stock C - Conversion I 150,612 150,612
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock P - Purchase I 5.0000 137,513 688 1,820,933
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners III, LP PHAS Common Stock C - Conversion I 1,683,420 1,683,420
2018-10-24 2018-10-22 4 Thorp Clay By Hatteras Venture Partners I, LP PHAS Common Stock C - Conversion I 52,690 52,690
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series D Preferred Stock C - Conversion I -30,334 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series D Preferred Stock C - Conversion I -6,413 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series D Preferred Stock C - Conversion I -63,688 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock C - Conversion I -22,452 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock C - Conversion I -4,746 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock C - Conversion I -47,140 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock C - Conversion I -165,395 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock C - Conversion I -34,968 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock C - Conversion I -347,250 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series AA Preferred Stock C - Conversion I -56,874 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series AA Preferred Stock C - Conversion I -12,025 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series AA Preferred Stock C - Conversion I -119,408 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -113 -1 22,452
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 4,690 1 22,565
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -4,690 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -24 -0 4,746
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 991 0 4,770
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -991 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock S - Sale I 5.0000 -237 -1 47,140
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series C-1 Preferred Stock M - Exercise I 0.1200 9,847 1 47,377
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series C-1 Preferred Stock M - Exercise I 0.12 -9,847 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -81 -0 165,395
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 3,359 0 165,476
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -3,359 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -18 -0 34,968
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 710 0 34,986
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -710 0
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock S - Sale I 5.0000 -170 -1 347,250
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Series B Preferred Stock M - Exercise I 0.1200 7,053 1 347,420
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Warrants to Purchase Series B Preferred Stock M - Exercise I 0.12 -7,053 0
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock P - Purchase I 5.0000 6,041 30 281,096
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II-B, LP PHAS Common Stock C - Conversion I 275,055 275,055
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock P - Purchase I 5.0000 1,277 6 59,429
2018-10-24 2018-10-22 4 TUFTS LINDA By FSV II, LP PHAS Common Stock C - Conversion I 58,152 58,152
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock P - Purchase I 5.0000 12,682 63 590,168
2018-10-24 2018-10-22 4 TUFTS LINDA By Fletcher Spaght Ventures II, LP PHAS Common Stock C - Conversion I 577,486 577,486
2018-10-17 2018-10-17 4 Mow Jonathan P PHAS Employee Stock Option (right to buy) A - Award D 5.00 220,000 220,000
2018-10-17 3 Thorp Clay PHAS Common Stock D 23,598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23,598
2018-10-17 3 Thorp Clay PHAS Common Stock D 23,598
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90,388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90,388
2018-10-17 3 Mow Jonathan P By the Mow Trust dated April 17, 2008 PHAS Common Stock I 90,388
P
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매입
S
공개 시장에서 또는 사적으로 비파생증권 또는 파생증권 매각
A
자사로부터 유가증권(옵션 등)을 보조, 지급 또는 기타 취득
C
파생상품 전환
D
자사에게 유가증권을 매각 또는 양도
F
기업으로부터 인도 받은 유가증권의 일부를 사용한 행사 가격 또는 조세 채무의 지급
G
내부자에 의한 또는 내부자에게 증권 증여
K
지분스왑 및 유사 위험 회피거래
M
자사로부터 인도 받은 파생증권(옵션 등)의 행사 또는 전환
V
보고서 양식 4에 자진 신고된 거래
J
기타 (거래 내용을 설명하는 각주와 동반)
How Much do you Like Fintel?
Please share your opinion of our service!
Excellent Bad
Fintel data has been cited in the following publications:
Daily Mail Fox Business Business Insider Wall Street Journal The Washington Post Bloomberg Financial Times Globe and Mail
NASDAQ.com Reuters The Guardian Associated Press FactCheck.org Snopes Politifact
Federal Register The Intercept Forbes Fortune Magazine TheStreet Time Magazine Canadian Broadcasting Corporation International Business Times
Cambridge University Press Investopedia MarketWatch NY Daily News Entrepreneur Newsweek Barron's El Economista